Zoetis Inc. Operating Cash Flow
Zoetis Inc. (ZTS) reported Operating Cash Flow of $1.06 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Zoetis Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $655.00M, a 8.26% increase year-over-year.
- Zoetis Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $401.00M, a 22.14% decline year-over-year.
- Zoetis Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $893.00M, a 1.33% decline year-over-year.
- Zoetis Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $891.00M, a 6.31% decline year-over-year.
- Zoetis Inc. net cash provided by (used in) operating activities for fiscal 2025 was $2.90B, a 1.66% decline from fiscal 2024.
- Zoetis Inc. net cash provided by (used in) operating activities for fiscal 2024 was $2.95B, a 25.50% increase from fiscal 2023.
- Zoetis Inc. net cash provided by (used in) operating activities for fiscal 2023 was $2.35B, a 23.06% increase from fiscal 2022.
- Zoetis Inc. net cash provided by (used in) operating activities for fiscal 2022 was $1.91B, a 13.60% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $655.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.06B 10-Q · filed 2026-08-06 | $1.95B derived: sum of 3 quarters · filed 2026-08-06 | $2.84B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $401.00M 10-Q · filed 2026-05-07 | $1.29B derived: sum of 2 quarters · filed 2026-05-07 | $2.19B derived: sum of 3 quarters · filed 2026-05-07 | $2.79B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $893.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.78B derived: sum of 2 quarters · filed 2026-02-12 | $2.39B derived: sum of 3 quarters · filed 2026-08-06 | $2.90B 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $891.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.50B derived: sum of 2 quarters · filed 2026-08-06 | $2.01B 10-Q · filed 2025-11-04 | $2.92B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $605.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.12B 10-Q · filed 2026-08-06 | $1.07B 10-Q · filed 2025-08-05 | $2.02B derived: sum of 3 quarters · filed 2026-08-06 | $2.98B derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $515.00M 10-Q · filed 2026-05-07 | $587.00M 10-Q · filed 2025-05-06 | $1.42B derived: sum of 2 quarters · filed 2026-05-07 | $2.37B derived: sum of 3 quarters · filed 2026-05-07 | $2.87B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $905.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.86B derived: sum of 2 quarters · filed 2026-02-12 | $2.36B derived: sum of 3 quarters · filed 2026-02-12 | $2.95B 10-K · filed 2026-02-12 | ||
| 2024-09-30 | $951.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.45B derived: sum of 2 quarters · filed 2025-11-04 | $2.05B 10-Q · filed 2025-11-04 | $2.94B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-06-30 | $502.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.10B 10-Q · filed 2025-08-05 | $1.99B derived: sum of 3 quarters · filed 2026-02-12 | $2.72B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-03-31 | $595.00M 10-Q · filed 2025-05-06 | $1.49B derived: sum of 2 quarters · filed 2026-02-12 | $2.22B derived: sum of 3 quarters · filed 2026-02-12 | $2.40B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2023-12-31 | $897.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.62B derived: sum of 2 quarters · filed 2026-02-12 | $1.80B derived: sum of 3 quarters · filed 2026-02-12 | $2.35B 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $724.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $907.00M derived: sum of 2 quarters · filed 2024-11-04 | $1.46B 10-Q · filed 2024-11-04 | $2.20B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-06-30 | $183.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $732.00M 10-Q · filed 2024-08-06 | $1.47B derived: sum of 3 quarters · filed 2025-02-13 | $2.00B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-03-31 | $549.00M 10-Q · filed 2024-05-02 | $1.29B derived: sum of 2 quarters · filed 2025-02-13 | $1.82B derived: sum of 3 quarters · filed 2025-02-13 | $2.15B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2022-12-31 | $741.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.27B derived: sum of 2 quarters · filed 2025-02-13 | $1.60B derived: sum of 3 quarters · filed 2025-02-13 | $1.91B 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $526.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $862.00M derived: sum of 2 quarters · filed 2023-11-02 | $1.17B 10-Q · filed 2023-11-02 | $1.85B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $336.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $645.00M 10-Q · filed 2023-08-08 | $1.32B derived: sum of 3 quarters · filed 2024-02-13 | $1.98B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $309.00M 10-Q · filed 2023-05-04 | $988.00M derived: sum of 2 quarters · filed 2024-02-13 | $1.64B derived: sum of 3 quarters · filed 2024-02-13 | $2.12B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $679.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.33B derived: sum of 2 quarters · filed 2024-02-13 | $1.81B derived: sum of 3 quarters · filed 2024-02-13 | $2.21B 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $653.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.13B derived: sum of 2 quarters · filed 2022-11-03 | $1.53B 10-Q · filed 2022-11-03 | $2.25B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $481.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $881.00M 10-Q · filed 2022-08-04 | $1.60B derived: sum of 3 quarters · filed 2023-02-14 | $2.16B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $400.00M 10-Q · filed 2022-05-05 | $1.12B derived: sum of 2 quarters · filed 2023-02-14 | $1.68B derived: sum of 3 quarters · filed 2023-02-14 | $2.12B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $718.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $1.28B derived: sum of 2 quarters · filed 2023-02-14 | $1.72B derived: sum of 3 quarters · filed 2023-02-14 | $2.13B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $562.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.00B derived: sum of 2 quarters · filed 2021-11-04 | $1.41B 10-Q · filed 2021-11-04 | $1.99B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-06-30 | $438.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $846.00M 10-Q · filed 2021-08-05 | $1.43B derived: sum of 3 quarters · filed 2022-02-15 | $1.93B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-03-31 | $408.00M 10-Q · filed 2021-05-06 | $990.00M derived: sum of 2 quarters · filed 2022-02-15 | $1.50B derived: sum of 3 quarters · filed 2022-02-15 | $1.81B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2019-12-31 | $582.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.09B derived: sum of 2 quarters · filed 2022-02-15 | $1.41B derived: sum of 3 quarters · filed 2022-02-15 | $1.79B 10-K · filed 2022-02-15 | ||
| 2019-09-30 | $506.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $824.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.21B 10-Q · filed 2020-11-05 | $1.80B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-06-30 | $318.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $707.00M 10-Q · filed 2020-08-06 | $1.29B derived: sum of 3 quarters · filed 2021-02-16 | $1.84B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-03-31 | $389.00M 10-Q · filed 2020-05-06 | $973.00M derived: sum of 2 quarters · filed 2021-02-16 | $1.52B derived: sum of 3 quarters · filed 2021-02-16 | $1.79B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2018-12-31 | $584.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $1.13B derived: sum of 2 quarters · filed 2021-02-16 | $1.40B derived: sum of 3 quarters · filed 2021-02-16 | $1.79B 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $550.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $817.00M derived: sum of 2 quarters · filed 2019-11-07 | $1.21B 10-Q · filed 2019-11-07 | $1.81B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $267.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $656.00M 10-Q · filed 2019-08-06 | $1.26B derived: sum of 3 quarters · filed 2020-02-13 | $1.70B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $389.00M 10-Q · filed 2019-05-02 | $997.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.44B derived: sum of 3 quarters · filed 2020-02-13 | $1.62B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $608.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $1.05B derived: sum of 2 quarters · filed 2020-02-13 | $1.23B derived: sum of 3 quarters · filed 2020-02-13 | $1.35B 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $439.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $619.00M derived: sum of 2 quarters · filed 2018-11-01 | $738.00M 10-Q · filed 2018-11-01 | $1.02B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-07-02 | $180.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $299.00M 10-Q · filed 2018-08-02 | $585.00M derived: sum of 3 quarters · filed 2019-02-14 | $824.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-04-02 | $119.00M 10-Q · filed 2018-05-02 | $405.00M derived: sum of 2 quarters · filed 2019-02-14 | $644.00M derived: sum of 3 quarters · filed 2019-02-14 | $781.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2016-12-31 | $286.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $525.00M derived: sum of 2 quarters · filed 2019-02-14 | $662.00M derived: sum of 3 quarters · filed 2019-02-14 | $713.00M 10-K · filed 2019-02-14 | ||
| 2016-10-02 | $239.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $376.00M derived: sum of 2 quarters · filed 2017-11-02 | $427.00M 10-Q · filed 2017-11-02 | $705.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-07-03 | $137.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $188.00M 10-Q · filed 2017-08-08 | $466.00M derived: sum of 3 quarters · filed 2018-02-15 | $670.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-04-03 | $51.00M 10-Q · filed 2017-05-04 | $329.00M derived: sum of 2 quarters · filed 2018-02-15 | $533.00M derived: sum of 3 quarters · filed 2018-02-15 | $655.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $278.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $482.00M derived: sum of 2 quarters · filed 2018-02-15 | $604.00M derived: sum of 3 quarters · filed 2018-02-15 | $664.00M 10-K · filed 2018-02-15 | ||
| 2015-09-27 | $204.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $326.00M derived: sum of 2 quarters · filed 2016-11-03 | $386.00M 10-Q · filed 2016-11-03 | $773.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-06-28 | $122.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $182.00M 10-Q · filed 2016-08-05 | $569.00M derived: sum of 3 quarters · filed 2017-02-16 | $672.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-03-29 | $60.00M 10-Q · filed 2016-05-06 | $447.00M derived: sum of 2 quarters · filed 2017-02-16 | $550.00M derived: sum of 3 quarters · filed 2017-02-16 | $709.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2014-12-31 | $387.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $490.00M derived: sum of 2 quarters · filed 2017-02-16 | $649.00M derived: sum of 3 quarters · filed 2017-02-16 | $626.00M 10-K · filed 2017-02-16 | ||
| 2014-09-28 | $103.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $262.00M derived: sum of 2 quarters · filed 2015-11-05 | $239.00M 10-Q · filed 2015-11-05 | $537.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $159.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $136.00M 10-Q · filed 2015-08-06 | $434.00M derived: sum of 3 quarters · filed 2016-02-24 | $548.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | -$23.00M 10-Q · filed 2015-05-07 | $275.00M derived: sum of 2 quarters · filed 2016-02-24 | $389.00M derived: sum of 3 quarters · filed 2016-02-24 | $377.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $298.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $412.00M derived: sum of 2 quarters · filed 2016-02-24 | $400.00M derived: sum of 3 quarters · filed 2016-02-24 | $681.00M 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $114.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $102.00M derived: sum of 2 quarters · filed 2014-11-10 | $383.00M 10-Q · filed 2014-11-10 | $693.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $269.00M 10-Q · filed 2014-08-12 | $579.00M derived: sum of 3 quarters · filed 2015-02-27 | $653.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $281.00M 10-Q · filed 2014-05-13 | $591.00M derived: sum of 2 quarters · filed 2015-02-27 | $665.00M derived: sum of 3 quarters · filed 2015-02-27 | $739.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $310.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $384.00M derived: sum of 2 quarters · filed 2015-02-27 | $458.00M derived: sum of 3 quarters · filed 2015-02-27 | $454.00M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $148.00M derived: sum of 2 quarters · filed 2013-11-13 | $144.00M 10-Q · filed 2013-11-13 | |||
| 2012-07-01 | $74.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $70.00M 10-Q · filed 2013-08-14 | ||||
| 2012-04-01 | -$4.00M 10-Q · filed 2013-05-15 | |||||
| 2011-12-31 | $497.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |